Silicon micromachining to tissue engineer branched vascular channels for liver fabrication.

PubWeight™: 1.71‹?› | Rank: Top 3%

🔗 View Article (PMID 10941206)

Published in Tissue Eng on April 01, 2000

Authors

S Kaihara1, J Borenstein, R Koka, S Lalan, E R Ochoa, M Ravens, H Pien, B Cunningham, J P Vacanti

Author Affiliations

1: Department of Surgery, Harvard Medical School and the Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

Articles citing this

Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66

Hydrogels in regenerative medicine. Adv Mater (2009) 3.80

Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 3.66

Vascularized organoid engineered by modular assembly enables blood perfusion. Proc Natl Acad Sci U S A (2006) 2.82

Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci U S A (2011) 2.03

Three-Dimensional Microfluidic Tissue-Engineering Scaffolds Using a Flexible Biodegradable Polymer. Adv Mater (2005) 1.49

In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat Commun (2013) 1.41

Cell culture on MEMS platforms: a review. Int J Mol Sci (2009) 1.23

Silk Fibroin Microfluidic Devices. Adv Mater (2007) 1.21

Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08

Optimal planar flow network designs for tissue engineered constructs with built-in vasculature. Ann Biomed Eng (2007) 1.04

Microfluidic techniques for development of 3D vascularized tissue. Biomaterials (2014) 1.02

Heart regeneration with engineered myocardial tissue. Annu Rev Biomed Eng (2014) 0.93

A microdevice for the creation of patent, three-dimensional endothelial cell-based microcirculatory networks. Biomicrofluidics (2011) 0.89

Principles of biomimetic vascular network design applied to a tissue-engineered liver scaffold. Tissue Eng Part A (2010) 0.89

Strategies for vascularization of polymer scaffolds. J Investig Med (2010) 0.88

Immune response to stem cells and strategies to induce tolerance. Philos Trans R Soc Lond B Biol Sci (2007) 0.86

Applications of microscale technologies for regenerative dentistry. J Dent Res (2009) 0.85

Chitin Nanofiber Micropatterned Flexible Substrates for Tissue Engineering(†) J Mater Chem B Mater Biol Med (2013) 0.83

Image-guided tissue engineering. J Cell Mol Med (2009) 0.82

The effect of scaffold macroporosity on angiogenesis and cell survival in tissue-engineered smooth muscle. Biomaterials (2014) 0.82

Embedding synthetic microvascular networks in poly(lactic acid) substrates with rounded cross-sections for cell culture applications. PLoS One (2013) 0.82

Experimental investigation and computational modeling of hydrodynamics in bifurcating microchannels. Biomed Microdevices (2008) 0.80

Microvascular engineering in perfusion culture: immunohistochemistry and CLSM findings. Head Face Med (2006) 0.80

Preservation of Capillary-beds in Rat Lung Tissue Using Optimized Chemical Decellularization. J Mater Chem B Mater Biol Med (2013) 0.80

Biomimetic design and fabrication of porous chitosan–gelatin liver scaffolds with hierarchical channel network. J Mater Sci Mater Med (2014) 0.79

Procedure for the development of multi-depth circular cross-sectional endothelialized microchannels-on-a-chip. J Vis Exp (2013) 0.77

Advances in tissue engineering. J Pediatr Surg (2015) 0.77

Flux characteristics of cell culture medium in rectangular microchannels. J Artif Organs (2011) 0.76

Recellularization of rat liver scaffolds by human liver stem cells. Tissue Eng Part A (2015) 0.76

Vascularization of three-dimensional engineered tissues for regenerative medicine applications. Acta Biomater (2016) 0.76

Perivascular cells and tissue engineering: Current applications and untapped potential. Pharmacol Ther (2016) 0.75

Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs. Crit Rev Biomed Eng (2015) 0.75

Technique for internal channelling of hydroentangled nonwoven scaffolds to enhance cell penetration. J Biomater Appl (2012) 0.75

Towards a Humanized Mouse Model of Liver Stage Malaria Using Ectopic Artificial Livers. Sci Rep (2017) 0.75

Tissue engineering and regenerative medicine research perspectives for pediatric surgery. Pediatr Surg Int (2010) 0.75

Articles by these authors

Tissue engineering. Science (1993) 19.65

A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials (2003) 3.63

Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics (1989) 3.38

The tourniquet in total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br (1999) 3.25

Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg (1997) 2.93

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA (1999) 2.79

Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A (1997) 2.74

Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry (1987) 2.65

Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J Immunol (1992) 2.32

Bioengineered teeth from cultured rat tooth bud cells. J Dent Res (2004) 2.31

Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials (1996) 2.27

In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85

Functional living trileaflet heart valves grown in vitro. Circulation (2000) 1.77

Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg (1998) 1.76

Tissue engineering of complex tooth structures on biodegradable polymer scaffolds. J Dent Res (2002) 1.61

Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Cell (1994) 1.61

Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials (1993) 1.57

Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem (1998) 1.53

Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr (1985) 1.52

Tissue-engineered growth of cartilage: the effect of varying the concentration of chondrocytes seeded onto synthetic polymer matrices. Int J Oral Maxillofac Surg (1994) 1.52

Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res (1997) 1.51

A polymer foam conduit seeded with Schwann cells promotes guided peripheral nerve regeneration. Tissue Eng (2000) 1.48

Tissue engineering: the challenges ahead. Sci Am (1999) 1.45

Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg (1991) 1.44

Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res (1993) 1.44

Tissue engineering: current state and prospects. Annu Rev Med (2001) 1.42

Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Transplant Proc (1997) 1.41

Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials (2004) 1.32

Tissue engineering: a 21st century solution to surgical reconstruction. Ann Thorac Surg (2001) 1.32

Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg (1998) 1.29

Congenital diaphragmatic hernia--a tale of two cities: the Boston experience. J Pediatr Surg (1997) 1.28

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int (2011) 1.26

Fetal diaphragmatic hernia: ultrasound diagnosis and clinical outcome in 38 cases. J Pediatr Surg (1989) 1.25

Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng (1991) 1.24

Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg (1995) 1.24

The NavChair Assistive Wheelchair Navigation System. IEEE Trans Rehabil Eng (1999) 1.21

Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood (1993) 1.20

Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials (1996) 1.16

Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol (1992) 1.16

Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation (2000) 1.16

Formation of phalanges and small joints by tissue-engineering. J Bone Joint Surg Am (1999) 1.15

Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg (1999) 1.15

Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation (1996) 1.14

An assessment of the brucellosis card test. Vet Rec (1971) 1.12

Histological Changes in the Rat Testis Following Heat Treatment. Yale J Biol Med (1940) 1.12

Studies of brush border enzymes, basement membrane components, and electrophysiology of tissue-engineered neointestine. J Pediatr Surg (1998) 1.11

Oral vitamin B12 can change our practice. Postgrad Med J (2003) 1.10

Prevascularization of porous biodegradable polymers. Biotechnol Bioeng (1993) 1.08

Paracetamol absorption from Paramax, Panadol and Solpadeine. Br J Clin Pharmacol (1983) 1.08

Tissue engineering of heart valves: in vitro experiences. Ann Thorac Surg (2000) 1.07

In vitro organogenesis of liver tissue. Ann N Y Acad Sci (1997) 1.07

New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng (2000) 1.06

Cardiovascular physiology during fetal development and implications for tissue engineering. Tissue Eng (2001) 1.06

Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation (1996) 1.06

Dynamic seeding and in vitro culture of hepatocytes in a flow perfusion system. Tissue Eng (2000) 1.05

Biodegradable sponges for hepatocyte transplantation. J Biomed Mater Res (1995) 1.05

Injectable cartilage. Plast Reconstr Surg (1995) 1.03

Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng (2000) 1.03

Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization. J Biol Chem (2000) 1.02

Transplantation of hepatocytes using porous, biodegradable sponges. Transplant Proc (1994) 1.01

Delayed repair and preoperative ECMO does not improve survival in high-risk congenital diaphragmatic hernia. J Pediatr Surg (1992) 1.01

De novo cartilage generation using calcium alginate-chondrocyte constructs. Plast Reconstr Surg (1996) 1.01

Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother (1997) 1.01

Bioengineered dental tissues grown in the rat jaw. J Dent Res (2008) 1.01

Hepatic retransplantation in New England--a regional experience and survival model. Transplantation (1993) 1.01

Temporomandibular joint disc replacement made by tissue-engineered growth of cartilage. J Oral Maxillofac Surg (1994) 1.01

Cartilage engineered in predetermined shapes employing cell transplantation on synthetic biodegradable polymers. Plast Reconstr Surg (1994) 1.01

Liver transplantation in newborn liver failure: treatment for neonatal hemochromatosis. Transplant Proc (1993) 0.99

Studies in rat liver perfusion for optimal harvest of hepatocytes. J Pediatr Surg (1990) 0.99

Toward development of an implantable tissue engineered liver. Biomaterials (1996) 0.99

Tissue-engineered growth of bone and cartilage. Transplant Proc (1993) 0.98

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate. Osteoporos Int (2010) 0.98

In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials (2000) 0.98

A review of the literature on the etiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesthetic Plast Surg (1999) 0.97

Engineering of implantable cartilaginous structures from bone marrow-derived mesenchymal stem cells. Tissue Eng (2007) 0.97

Tissue engineering: biomedical applications. Tissue Eng (1995) 0.97

Soft-tissue augmentation with injectable alginate and syngeneic fibroblasts. Plast Reconstr Surg (2000) 0.97

Stability of reamed and unreamed intramedullary tibial nails: a biomechanical study. Injury (1995) 0.97

Fetal tissue engineering: diaphragmatic replacement. J Pediatr Surg (2001) 0.96

Skeletal muscle tissue engineering using isolated myoblasts on synthetic biodegradable polymers: preliminary studies. Tissue Eng (1999) 0.96

The health burden of breast hypertrophy. Plast Reconstr Surg (2001) 0.96

Performance monitoring of mycobacterium tuberculosis dried culture spots for use with the GeneXpert system within a national program in South Africa. J Clin Microbiol (2013) 0.96

Tissue-engineered spinal cord. Transplant Proc (2001) 0.96

Activating CTL precursors to reveal CTL function without skewing the repertoire by in vitro expansion. Eur J Immunol (2001) 0.95

Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant (1994) 0.95

Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures. J Cell Biochem (2001) 0.94

Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves. ASAIO J (2000) 0.94

Dall-Miles cable and plate fixation for the treatment of peri-prosthetic femoral fractures-analysis of results in 13 cases. Injury (2001) 0.94

Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg (2000) 0.93

The non-operative management of radial head fractures: a randomized trial of three treatments. Injury (1994) 0.92

Hepatocyte culture on biodegradable polymeric substrates. Biotechnol Bioeng (1991) 0.92

Solid-phase capture of proteins, spores, and bacteria. Appl Environ Microbiol (2001) 0.92

Pulmonary growth and remodeling in infants with high-risk congenital diaphragmatic hernia. J Pediatr Surg (1992) 0.91

Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza A virus matrix protein. Hum Immunol (1993) 0.91

Congenital diaphragmatic hernia: predictors of severity in the ECMO era. J Pediatr Surg (1991) 0.91

The NavBelt--a computerized travel aid for the blind based on mobile robotics technology. IEEE Trans Biomed Eng (1998) 0.91

Aspergillus fumigatus infection in a mega prosthetic total knee arthroplasty: salvage by staged reimplantation with 5-year follow-up. J Arthroplasty (2001) 0.91

Tissue engineering of heart valves -- current aspects. Thorac Cardiovasc Surg (2002) 0.91